| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
146,000,000 |
| Market
Cap: |
16.87(B) |
| Last
Volume: |
1,904,666 |
Avg
Vol: |
1,333,207 |
| 52
Week Range: |
$92.79 - $212.65 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Electronics |
| Level
III Sector: |
Scientific & Technical Instruments |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : 11.4 |
| Insider 6 Months : 11.4 |
| Insider 3/6 Months : 23.2 |
|
| Guru Rank Number : 691 |
| Guru Rank Value : 2.3 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Illumina is engaged in sequencing- and array-based solutions for genetic and genomic analysis. Co. provides whole-genome sequencing, genotyping, noninvasive prenatal testing (NIPT), and product support services. Using Co.'s services, customers can perform whole-genome sequencing projects and microarray projects (including large-scale genotyping studies and whole-genome association studies). Co. provides NIPT services through its partner laboratories that direct samples to Co. on a test send-out basis in its Clinical Laboratory Improvements Amendments-certified, College of Pathologists-accredited laboratory. Co. also provides support services to customers who have purchased its products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
7,330 |
7,330 |
7,330 |
7,330 |
| Total Buy Value |
$991,672 |
$991,672 |
$991,672 |
$991,672 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
1 |
1 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
6,815 |
22,740 |
| Total Sell Value |
$0 |
$0 |
$1,357,080 |
$4,648,975 |
| Total People Sold |
0 |
0 |
2 |
3 |
| Total Sell Transactions |
0 |
0 |
5 |
17 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Flatley Jay T |
Director |
• • – |
2021-01-05 |
4 |
AS |
$365.27 |
$1,461,080 |
D/D |
(4,000) |
184,933 |
|
2% |
|
| Tousi Susan H |
SVP Product Development |
• • – |
2021-01-05 |
4 |
AS |
$365.27 |
$109,581 |
D/D |
(300) |
42,947 |
|
2% |
|
| Desouza Francis A |
President and CEO |
• • – |
2021-01-04 |
4 |
AS |
$366.84 |
$1,111,537 |
D/D |
(3,000) |
55,540 |
|
2% |
|
| Arnold Frances |
Director |
• • – |
2020-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
10 |
10,927 |
|
- |
|
| Flatley Jay T |
Director |
• • – |
2020-12-15 |
4 |
AS |
$348.84 |
$1,395,360 |
D/D |
(4,000) |
188,933 |
|
17% |
|
| Hoyt Aimee L |
SVP, Chief People Officer |
• • – |
2020-12-14 |
4 |
AS |
$345.00 |
$122,130 |
D/D |
(354) |
2,744 |
|
21% |
|
| Ronaghi Mostafa |
SVP, Entrepreneurial Devlopmt |
• • – |
2020-12-10 |
4 |
AS |
$336.92 |
$1,692,922 |
D/D |
(5,000) |
80,162 |
|
19% |
|
| Tousi Susan H |
SVP Product Development |
• • – |
2020-12-07 |
4 |
AS |
$348.03 |
$104,803 |
D/D |
(300) |
43,247 |
|
18% |
|
| Tousi Susan H |
SVP Product Development |
• • – |
2020-12-04 |
4 |
AS |
$350.00 |
$70,000 |
D/D |
(200) |
43,547 |
|
14% |
|
| Flatley Jay T |
Director |
• • – |
2020-12-01 |
4 |
AS |
$323.86 |
$1,295,590 |
D/D |
(4,000) |
192,933 |
|
21% |
|
| Dadswell Charles |
SVP & General Counsel |
• • – |
2020-12-01 |
4 |
AS |
$323.86 |
$548,619 |
D/D |
(1,694) |
3,460 |
|
21% |
|
| Desouza Francis A |
President and CEO |
• • – |
2020-12-01 |
4 |
AS |
$323.83 |
$983,851 |
D/D |
(3,000) |
58,540 |
|
21% |
|
| Tousi Susan H |
SVP Product Development |
• • – |
2020-12-01 |
4 |
AS |
$325.00 |
$32,500 |
D/D |
(100) |
43,747 |
|
21% |
|
| Ragusa Robert P |
SVP, Global Quality & Ops |
• • – |
2020-11-30 |
4 |
AS |
$311.34 |
$909,827 |
D/D |
(2,890) |
4,092 |
|
24% |
|
| Mcginnis Karen K |
VP, Chief Accounting Officer |
• • – |
2020-11-18 |
4 |
AS |
$300.00 |
$65,400 |
D/D |
(218) |
1,538 |
|
30% |
|
| Flatley Jay T |
Director |
• • – |
2020-11-17 |
4 |
AS |
$296.73 |
$891,470 |
D/D |
(3,000) |
196,933 |
|
24% |
|
| Mcginnis Karen K |
VP, Chief Accounting Officer |
• • – |
2020-11-14 |
4 |
D |
$296.73 |
$34,421 |
D/D |
(116) |
1,756 |
|
- |
|
| Febbo Phillip G. |
SVP Chief Medical Officer |
• • – |
2020-11-06 |
4 |
AS |
$310.10 |
$48,066 |
D/D |
(155) |
2,143 |
|
35% |
|
| Hoyt Aimee L |
SVP, Chief People Officer |
• • – |
2020-11-06 |
4 |
AS |
$310.10 |
$66,672 |
D/D |
(215) |
3,098 |
|
35% |
|
| Mcginnis Karen K |
VP, Chief Accounting Officer |
• • – |
2020-11-06 |
4 |
AS |
$310.10 |
$96,751 |
D/D |
(312) |
1,872 |
|
35% |
|
| Febbo Phillip G. |
SVP Chief Medical Officer |
• • – |
2020-11-05 |
4 |
D |
$311.72 |
$59,850 |
D/D |
(192) |
2,298 |
|
- |
|
| Ragusa Robert P |
SVP, Global Quality & Ops |
• • – |
2020-11-05 |
4 |
D |
$311.72 |
$349,438 |
D/D |
(1,121) |
6,982 |
|
- |
|
| Hoyt Aimee L |
SVP, Chief People Officer |
• • – |
2020-11-05 |
4 |
D |
$311.72 |
$57,668 |
D/D |
(185) |
3,313 |
|
- |
|
| Desouza Francis A |
President and CEO |
• • – |
2020-11-05 |
4 |
D |
$311.72 |
$1,340,396 |
D/D |
(4,300) |
61,540 |
|
- |
|
| Dadswell Charles |
SVP & General Counsel |
• • – |
2020-11-05 |
4 |
D |
$311.72 |
$274,937 |
D/D |
(882) |
5,154 |
|
- |
|
3455 Records found
|
|
Page 12 of 139 |
|
|
2.81 (2.49%) 
